Source:http://linkedlifedata.com/resource/pubmed/id/16165215
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-1
|
pubmed:abstractText |
The [M(ESDT)Cl](n) (M=Pt(II), Pd(II); ESDT=EtO(O)CCH(2)N(CH(3))CS(2)(-), ethylsarcosinedithiocarbamate ion) species have been reacted with 2- or 3-picoline in dichloromethane in order to obtain mixed ligand complexes of the type [M(ESDT)(L)Cl] (L=2-picoline, 3-picoline). The synthesized compounds have been isolated, purified and characterized by means of elemental analyses, (1)H-/(13)C-/(1)H(13)C-HMBC (heteronuclear multiple bonding coherence) NMR and FT-IR spectroscopy. The biological activity of the compounds reported here has been then determined in terms of cell growth inhibition, DNA synthesis inhibition, detection of interstrand cross-links and DNA-protein cross-links, and micronuclei (MN) detection on a panel of tumor cell lines both sensitive and resistant to cisplatin. On the basis of the experimental results, coordination in the above mentioned complexes takes place in a near square-planar geometry, the dithiocarbamate moiety acting as a chelating agent, whereas the two remaining coordination sites are occupied by a chlorine atom and an amino ligand. Above all, [Pt(ESDT)(2-picoline)Cl] complex has shown very encouraging cytotoxicity levels higher or, at least, comparable to those exerted by cisplatin in the same experimental conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Palladium,
http://linkedlifedata.com/resource/pubmed/chemical/Picolines,
http://linkedlifedata.com/resource/pubmed/chemical/Platinum,
http://linkedlifedata.com/resource/pubmed/chemical/Sarcosine,
http://linkedlifedata.com/resource/pubmed/chemical/Thiocarbamates,
http://linkedlifedata.com/resource/pubmed/chemical/sarcosine dithiocarbamate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0162-0134
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2139-50
|
pubmed:meshHeading |
pubmed-meshheading:16165215-Antineoplastic Agents,
pubmed-meshheading:16165215-Cell Line, Tumor,
pubmed-meshheading:16165215-Cells, Cultured,
pubmed-meshheading:16165215-HL-60 Cells,
pubmed-meshheading:16165215-HeLa Cells,
pubmed-meshheading:16165215-Humans,
pubmed-meshheading:16165215-Palladium,
pubmed-meshheading:16165215-Picolines,
pubmed-meshheading:16165215-Platinum,
pubmed-meshheading:16165215-Sarcosine,
pubmed-meshheading:16165215-Spectroscopy, Fourier Transform Infrared,
pubmed-meshheading:16165215-Thiocarbamates
|
pubmed:year |
2005
|
pubmed:articleTitle |
Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents.
|
pubmed:affiliation |
University Department of Chemical Sciences, via Marzolo 1, 35131 Padua, Italy.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|